| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Northpond Ventures II Gp, LLC last filed a Form 4 in October 2024, as 10% Owner at CAMP.
At the last filing, the largest reported position was 763,636 shares of CAMP. Net of sales, the CAMP filings show accumulation of 763,636 shares.
Northpond Ventures II Gp, LLC has 1 Form 4 filing on record in October 2024, as 10% Owner at Camp4 Therapeutics (CAMP), 2024.
The 3 reported transactions were 2 conversions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $8.4M and no sales.
The only open-market purchase was 763,636 shares of CAMP at an average $11.00 on October 15, 2024, about $8.4M. Twelve months later CAMP was down 68%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 763,636 | $11.00 | $8,399,996.00 | New | -63.3% | -68.0% |